Vimarsana
Biggest News Aggregation in the World

Chromadex External Research Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chromadex External Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chromadex External Research Program Today - Breaking & Trending Today

NutraIngredients Awards 2024 Winners announced! - Vimarsana News

NutraIngredients Awards 2024 Winners announced!

NutraIngredients celebrated one decade of annual industry awards last night (May 15) with the winners of this year's competition announced at a VIP Party in Geneva.

ChromaDex CEO calls for trust, innovation and self-policing in supplements industry - Vimarsana News

ChromaDex CEO calls for trust, innovation and self-policing in supplements industry

ChromaDex CEO Rob Fried advocates for the formation of a new group "consisting of industry players endeavoring to be righteous in their practices."

Parkinson's disease: NR, a form of vitamin B3, may help with symptoms - Vimarsana News

Parkinson's disease: NR, a form of vitamin B3, may help with symptoms

Recent research suggests that taking supplements of NR, a form of vitamin B3, could lead to symptom improvement in people with Parkinson's disease.

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD) - Vimarsana News

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD)

LOS ANGELES--(BUSINESS WIRE)--Nov 30, 2023--

ChromaDex launches 'clinical strength' Tru Niagen Pro - Vimarsana News

ChromaDex launches 'clinical strength' Tru Niagen Pro

California-based ChromaDex Corp. has launched a high dose Tru Niagen product containing 1,000 mg of its Nicotinamide Riboside ingredient.